List of Tables
    Table 1. Radiopharmaceuticals in Nuclear Medical CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Radiopharmaceuticals in Nuclear Medical Market Trends
    Table 3. Radiopharmaceuticals in Nuclear Medical Market Drivers
    Table 4. Radiopharmaceuticals in Nuclear Medical Market Challenges
    Table 5. Radiopharmaceuticals in Nuclear Medical Market Restraints
    Table 6. Global Radiopharmaceuticals in Nuclear Medical Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Radiopharmaceuticals in Nuclear Medical Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Radiopharmaceuticals in Nuclear Medical Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Radiopharmaceuticals in Nuclear Medical Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Radiopharmaceuticals in Nuclear Medical Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Radiopharmaceuticals in Nuclear Medical Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Radiopharmaceuticals in Nuclear Medical Sales Share by Manufacturer, 2017-2022
    Table 15. Global Radiopharmaceuticals in Nuclear Medical Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Radiopharmaceuticals in Nuclear Medical Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Radiopharmaceuticals in Nuclear Medical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2021)
    Table 18. Top Players of Radiopharmaceuticals in Nuclear Medical in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
    Table 20. Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Radiopharmaceuticals in Nuclear Medical Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Radiopharmaceuticals in Nuclear Medical Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Radiopharmaceuticals in Nuclear Medical Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Radiopharmaceuticals in Nuclear Medical Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Radiopharmaceuticals in Nuclear Medical Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Radiopharmaceuticals in Nuclear Medical Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Radiopharmaceuticals in Nuclear Medical Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Radiopharmaceuticals in Nuclear Medical Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Radiopharmaceuticals in Nuclear Medical Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Radiopharmaceuticals in Nuclear Medical Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Radiopharmaceuticals in Nuclear Medical Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Radiopharmaceuticals in Nuclear Medical Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Radiopharmaceuticals in Nuclear Medical Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Radiopharmaceuticals in Nuclear Medical Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Radiopharmaceuticals in Nuclear Medical Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Radiopharmaceuticals in Nuclear Medical Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bracco Imaging Corporation Information
    Table 43. Bracco Imaging Description and Business Overview
    Table 44. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product
    Table 46. Bracco Imaging Recent Development
    Table 47. Cambridge Isotope Laboratories Corporation Information
    Table 48. Cambridge Isotope Laboratories Description and Business Overview
    Table 49. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Cambridge Isotope Laboratories Product
    Table 51. Cambridge Isotope Laboratories Recent Development
    Table 52. Cardinal Health Corporation Information
    Table 53. Cardinal Health Description and Business Overview
    Table 54. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Cardinal Health Product
    Table 56. Cardinal Health Recent Development
    Table 57. Medtronic Corporation Information
    Table 58. Medtronic Description and Business Overview
    Table 59. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Medtronic Product
    Table 61. Medtronic Recent Development
    Table 62. Eczacibasi-Monrol Corporation Information
    Table 63. Eczacibasi-Monrol Description and Business Overview
    Table 64. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Eczacibasi-Monrol Product
    Table 66. Eczacibasi-Monrol Recent Development
    Table 67. Fujifilm Holdings Corporation Corporation Information
    Table 68. Fujifilm Holdings Corporation Description and Business Overview
    Table 69. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Fujifilm Holdings Corporation Product
    Table 71. Fujifilm Holdings Corporation Recent Development
    Table 72. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
    Table 73. GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
    Table 74. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. GE Healthcare (Subsidiary Of General Electric Company) Product
    Table 76. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
    Table 77. IBA Group Corporation Information
    Table 78. IBA Group Description and Business Overview
    Table 79. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. IBA Group Product
    Table 81. IBA Group Recent Development
    Table 82. Lantheus Medical Imaging Corporation Information
    Table 83. Lantheus Medical Imaging Description and Business Overview
    Table 84. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Lantheus Medical Imaging Product
    Table 86. Lantheus Medical Imaging Recent Development
    Table 87. Nordion Corporation Information
    Table 88. Nordion Description and Business Overview
    Table 89. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Nordion Product
    Table 91. Nordion Recent Development
    Table 92. Ntp Radioisotopes Corporation Information
    Table 93. Ntp Radioisotopes Description and Business Overview
    Table 94. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Ntp Radioisotopes Product
    Table 96. Ntp Radioisotopes Recent Development
    Table 97. Siemens Healthcare Corporation Information
    Table 98. Siemens Healthcare Description and Business Overview
    Table 99. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. Siemens Healthcare Product
    Table 101. Siemens Healthcare Recent Development
    Table 102. Taiyo Nippon Sanso Corporation Corporation Information
    Table 103. Taiyo Nippon Sanso Corporation Description and Business Overview
    Table 104. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. Taiyo Nippon Sanso Corporation Product
    Table 106. Taiyo Nippon Sanso Corporation Recent Development
    Table 107. Urenco Limited Corporation Information
    Table 108. Urenco Limited Description and Business Overview
    Table 109. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Urenco Limited Product
    Table 111. Urenco Limited Recent Development
    Table 112. Rotem Industries Corporation Information
    Table 113. Rotem Industries Description and Business Overview
    Table 114. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Rotem Industries Product
    Table 116. Rotem Industries Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Radiopharmaceuticals in Nuclear Medical Customers List
    Table 120. Radiopharmaceuticals in Nuclear Medical Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Radiopharmaceuticals in Nuclear Medical Product Picture
    Figure 2. Global Radiopharmaceuticals in Nuclear Medical Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Radiopharmaceuticals in Nuclear Medical Market Size 2017-2028 (US$ Million)
    Figure 4. Global Radiopharmaceuticals in Nuclear Medical Sales 2017-2028 (K MT)
    Figure 5. United States Radiopharmaceuticals in Nuclear Medical Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Radiopharmaceuticals in Nuclear Medical Market Size 2017-2028 (US$ Million)
    Figure 7. United States Radiopharmaceuticals in Nuclear Medical Sales 2017-2028 (K MT)
    Figure 8. United States Radiopharmaceuticals in Nuclear Medical Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Radiopharmaceuticals in Nuclear Medical Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Radiopharmaceuticals in Nuclear Medical Report Years Considered
    Figure 11. Product Picture of Diagnostic Radiopharmaceuticals
    Figure 12. Product Picture of Therapy Radiopharmaceuticals
    Figure 13. Product Picture of Enriched Stable Isotopes
    Figure 14. Global Radiopharmaceuticals in Nuclear Medical Market Share by Type in 2022 & 2028
    Figure 15. Global Radiopharmaceuticals in Nuclear Medical Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028) & (K MT)
    Figure 18. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2017-2028) & (USD/MT)
    Figure 20. United States Radiopharmaceuticals in Nuclear Medical Market Share by Type in 2022 & 2028
    Figure 21. United States Radiopharmaceuticals in Nuclear Medical Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028) & (K MT)
    Figure 24. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Radiopharmaceuticals in Nuclear Medical Price by Type (2017-2028) & (USD/MT)
    Figure 26. Product Picture of Diagnostic Application
    Figure 27. Product Picture of Therapeutic Application
    Figure 28. Product Picture of Research
    Figure 29. Product Picture of Pharmaceutical
    Figure 30. Product Picture of Industrial
    Figure 31. Global Radiopharmaceuticals in Nuclear Medical Market Share by Application in 2022 & 2028
    Figure 32. Global Radiopharmaceuticals in Nuclear Medical Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028) & (K MT)
    Figure 35. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2017-2028) & (USD/MT)
    Figure 37. United States Radiopharmaceuticals in Nuclear Medical Market Share by Application in 2022 & 2028
    Figure 38. United States Radiopharmaceuticals in Nuclear Medical Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028) & (K MT)
    Figure 41. United States Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Radiopharmaceuticals in Nuclear Medical Price by Application (2017-2028) & (USD/MT)
    Figure 43. North America Radiopharmaceuticals in Nuclear Medical Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 44. North America Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Radiopharmaceuticals in Nuclear Medical Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 48. Europe Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 55. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Radiopharmaceuticals in Nuclear Medical Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 67. Latin America Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 72. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Radiopharmaceuticals in Nuclear Medical Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Radiopharmaceuticals in Nuclear Medical Value Chain
    Figure 77. Radiopharmaceuticals in Nuclear Medical Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed